Cargando…
Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?
Therapeutic repurposing emerged as an alternative to the traditional drug discovery and development model (DDD) of new molecular entities (NMEs). It was anticipated that by being faster, safer, and cheaper, the development would result in lower-cost drugs. As defined in this work, a repurposed cance...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097740/ https://www.ncbi.nlm.nih.gov/pubmed/36884210 http://dx.doi.org/10.1007/s40261-023-01251-0 |